Tef polymorphism is associated with sleep disturbances in patients with Parkinson's disease

Sleep Medicine

Volumn 13, Issue 3, 2012, Pages 297-300

  Hua, Ping ^a   Liu, Weiguo ^a   Zhao, Yanyan ^a   Ding, Haixia ^b   Wang, Li ^a   Xiao, Hong ^a  

^a THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Circadian rhythm; Clock genes; Parkinson's disease; Polymorphism; Sleep; Tef

Indexed keywords

GENOMIC DNA; GUANOSINE; PROTEIN; TEF PROTEIN; THYMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; TEF GENE; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL ANALOG SCALE;

AGED; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CIRCADIAN RHYTHM; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 84862824599     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.06.023     Document Type: Article

References (35)

1. Tandberg E., Larsen J.P., Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998, 13:895-899.
2. Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988, 6:512-519.
3. Visser M., Verbaan D., van Rooden S., Marinus J., van Hilten J., Stiggelbout A. A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 2009, 12:392-396.
4. Barone P., Amboni M., Vitale C., Bonavita V. Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. Neurology 2004, 63(Suppl. 3):S35-S38.
5. Comella C.L. Sleep disorders in Parkinson's disease: an overview. Mov Disord 2007, 22(Suppl. 17):S367-S673.
6. Franken P., Dijk D.J. Circadian clock genes and sleep homeostasis. Eur J Neurosci 2009, 29:1820-1829.
7. Schulz P., Steimer T. Neurobiology of circadian systems. CNS Drugs 2009, 23(Suppl. 2):3-13.
8. Partinen M., Kaprio J., Koskenvuo M., Putkonen P., Langinvainio H. Genetic and environmental determination of human sleep. Sleep 1983, 6:179-185.
9. Heath A.C., Kendler K.S., Eaves L.J., Martin N.G. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep 1990, 13:318-335.
10. Klei L., Reitz P., Miller M., et al. Heritability of morningness-eveningness and self-report sleep measures in a family-based sample of 521 hutterites. Chronobiol Int 2005, 22:1041-1054.
11. Watson N.F., Goldberg J., Arguelles L., Buchwald D. Genetic and environmental influences on insomnia, daytime sleepiness, and obesity in twins. Sleep 2006, 29:645-649.
12. Kyriacou C.P., Hastings M.H. Circadian clocks: genes, sleep, and cognition. Trends Cogn Sci 2010, 14:259-267.
13. Allebrandt K.V., Teder-Laving M., Akyol M., et al. CLOCK gene variants associate with sleep duration in two independent populations. Biol Psychiatry 2010, 67:1040-1047.
14. Kripke D.F., Shadan F.F., Dawson A., et al. Genotyping sleep disorders patients. Psychiatry Investig 2010, 7:36-42.
15. Kripke D.F., Nievergelt C.M., Joo E.J., Shekhtman T., Kelsoe J.R. Circadian polymorphisms associated with affective disorders. J Circadian Rhythms 2009, 7:2-11.
16. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
17. Chaudhuri K.R., Pal S., DiMarco A., et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002, 73:629-635.
18. Minguez-Castellanos A., Escamilla-Sevilla F., Katati M.J., et al. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?. J Neurol Neurosurg Psychiatry 2005, 76:34-39.
19. Wang G., Cheng Q., Zeng J., et al. Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale. J Neurol Sci 2008, 271:153-157.
20. Trenkwalder C., Kohnen R., Högl B., et al. Parkinson's disease sleep scale - validation of the revised version PDSS-2. Mov Disord 2011, 26:644-652.
21. Crum R.M., Anthony J.C., Bassett S.S., Folstein M.F. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993, 269:2386-2391.
22. Ke X., Collins A., Ye S. PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 2001, 17:838-839.
23. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
24. Borek L.L., Kohn R., Friedman J.H. Mood and sleep in Parkinson's disease. J Clin Psychiatry 2006, 67:958-963.
25. Martinez-Martin P., Visser M., Rodriguez-Blazquez C., Marinus J., Chaudhuri K.R., Van Hilten J.J. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. J Mov Disord 2008, 23:1681-1688.
26. Chaudhuri K.R., Martinez-Martin P. Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's Disease Sleep Scale. Neurology 2004, 63(Suppl. 3):S17-S20.
27. Dhawan V., Healy D.G., Pal S., Chaudhuri K.R. Sleep-related problems of Parkinson's disease. Age Ageing 2006, 35:220-228.
28. Gachon F., Fonjallaz P., Damiola F., et al. The loss of circadian PAR bZip transcription factors results in epilepsy. Genes Dev 2004, 18:1397-1412.
29. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004, 5:385-391.
30. Eisensehr I., Linke R., Tatsch K., et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003, 26:507-512.
31. Albin R.L., Koeppe R.A., Chervin R.D., et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000, 55:1410-1412.
32. Yoshimura N., Mizuta E., Kuno S., Sasa M., Yoshida O. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by MPTP. Neuropharmacology 1993, 32:315-321.
33. Dardente H., Wyse C.A., Birnie M.J., et al. A molecular switch for photoperiod responsiveness in mammals. Curr Biol 2010, 20:2193-2198.
34. Gachon F., Nagoshi E., Brown S.A., Ripperger J., Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004, 113:103-112.
35. Stranger B.E., Forrest M.S., Dunning M., et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007, 315:848-853.